Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S John Wort

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
ERJ Open Research|December 24, 2025
Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtypeIfan Jenkin, Konstantinos Dimopoulos, Steven D Nathan, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2020
Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic ObservationsBrijesh V Patel, Deepa J Arachchillage, Carole A Ridge, et al.
Pulmonary Circulation|April 15, 2020
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?Andrew J Peacock, Yi Ling, Martin K Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and IrelandYi Ling, Martin K Johnson, David G Kiely, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 23, 2026
Long term effects of medical therapy pre- and post- pulmonary endarterectomy - insights from the UK CURATE registryPaula Appenzeller, Ashwin Reddy, Hakim Ghani, et al.
Circulation|November 25, 2016
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial HypertensionChristopher J Rhodes, Pavandeep Ghataorhe, John Wharton, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|December 8, 2025
Paediatric pulmonary arterial hypertension following congenital heart defect repair: Enhanced risk stratification and outcomes in a national cohortAndrew Constantine, Konstantinos Dimopoulos, Robin Condliffe, et al.
The European Respiratory Journal|July 8, 2020
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre studyRobert A Lewis, Iain Armstrong, Carmel Bergbaum, et al.
The European Respiratory Journal|September 30, 2021
Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertensionMark Toshner, Colin Church, Lars Harbaum, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2022
Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial HypertensionRowena J Jones, Eckart M D D De Bie, Emily Groves, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
ERJ Open Research|December 24, 2025
Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtypeIfan Jenkin, Konstantinos Dimopoulos, Steven D Nathan, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2020
Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic ObservationsBrijesh V Patel, Deepa J Arachchillage, Carole A Ridge, et al.
Pulmonary Circulation|April 15, 2020
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?Andrew J Peacock, Yi Ling, Martin K Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and IrelandYi Ling, Martin K Johnson, David G Kiely, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 23, 2026
Long term effects of medical therapy pre- and post- pulmonary endarterectomy - insights from the UK CURATE registryPaula Appenzeller, Ashwin Reddy, Hakim Ghani, et al.
Circulation|November 25, 2016
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial HypertensionChristopher J Rhodes, Pavandeep Ghataorhe, John Wharton, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|December 8, 2025
Paediatric pulmonary arterial hypertension following congenital heart defect repair: Enhanced risk stratification and outcomes in a national cohortAndrew Constantine, Konstantinos Dimopoulos, Robin Condliffe, et al.
The European Respiratory Journal|July 8, 2020
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre studyRobert A Lewis, Iain Armstrong, Carmel Bergbaum, et al.
The European Respiratory Journal|September 30, 2021
Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertensionMark Toshner, Colin Church, Lars Harbaum, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2022
Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial HypertensionRowena J Jones, Eckart M D D De Bie, Emily Groves, et al.
Pageof 4